How to Invest in California’s Cannabis Industry
November 14th, 2017
News, Top News
California’s cannabis industry could be worth more than $25 billion per year over the coming years following adult-use legalization next year, according to many analysts covering the industry. While there are many different opportunities across the value chain, investors may want to consider scalable and diversified operations to maximize their risk-adjusted returns given the industry’s volatility and significant pent-up demand.
In this article, we will take a look at the projected size of California’s cannabis industry and where investors should look for opportunities in the space, including FinCanna Capital Corp., which is a royalty company that has already made a name for itself in the space. CFN has previously covered the company and its plans to fund Cultivation Technologies Inc (CTI) to build CTI’s proposed Coachella Campus in southern California.
How Big Will the Market Be?
California already has a medical marijuana market that generates about $845 million per year in revenue with nearly 3,000 dispensaries, according to Marijuana Business Daily, which notes that it’s difficult to estimate the size of the market given a lack of statewide regulation. Other estimates put annual revenue at closer to $2 billion per year, saying that many dispensaries are likely underreporting their sales given the lack of oversight.
After voting to legalize adult-use marijuana on Proposition 64, California will introduce a statewide adult use marijuana program in 2018. A new state-sponsored study suggests that this market could be worth more than $5 billion per year and make the state a destination for so-called ‘pot tourism’. Other analysts believe that the market could be much larger given the explosive growth seen in states like Colorado and Washington.
Cowen & Co. believes that the nation’s legal cannabis industry could reach $50 billion by 2026, with California accounting for about $25 billion of that market. ArcView Market Research analysts similarly believe that the national legal marijuana industry will grow at a 31% compound annual growth rate to reach more than $22 billion by 2020, with California accounting for a majority of the revenue when the program scales up.
Where Are the Best Opportunities
There are many different opportunities in the legal cannabis industry, including cultivation, retail, and ancillary products and services. Cultivation offers the most direct exposure to cannabis, but could experience commoditization over time. Retail dispensaries could benefit from immediate revenue, but will likely face growing competition over time. And, ancillary products and services don’t enjoy the same regulatory barriers to entry as the rest of the industry.
The key to success is building diversified exposure to the industry to help mitigate any individual risks of each industry subset and benefit from the growth as a whole. At the same time, the companies building the largest operations early on will benefit from economies of scale as the industry matures, which can help preserve margins and expand revenue.
In Desert Hot Springs, MedMen and G FarmaLabs are both building cultivation facilities two hours away from Los Angeles. FinCanna Capital Corp. is a royalty company that invests in cannabis operations in exchange for a percentage of revenue. It’s initial partner, Cultivation Technologies Inc., is working on a large-scale project in Coachella, which when complete, will consist of an 111,500 sq. ft. facility housing a cultivation center, extraction facility, and ancillary support. Upon completion of the Coachella Campus, FinCanna will earn a royalty of 10% of revenue from the project as a financier of the operation and also has rights to fund future CTI projects.
Interestingly, FinCanna recently announced that it will share in 50% of the profits from CTI’s interim medical cannabis extraction facility that’s currently operating in Coachella. The new arrangement provides the company with a source of monthly revenue before the construction of CTI’s Coachella Campus is completed as planned. The lab has already begun to produce medical extracts for sale and is expected to remain open during construction.
FinCanna plans to go public in Canada this year, which could open the door to retail investors. In the meantime, investors can sign-up to express interest using the link below. Accredited investors have an opportunity to participate in its pre-public financing that could provide early access to the company ahead of its going public transaction.
There are also many ancillary businesses involved with everything from cannabis testing to packaging and labeling. For instance, Kush Bottles Inc. (OTCQB: KSHB) focuses on producing cannabis related packaging and keeps arms-length distance from the product itself, which remains illegal on a federal level as a Schedule I Controlled Substance. Other companies specialize in providing lighting technologies or growing equipment.
California’s cannabis industry is projected to be worth upwards of $25 billion over the coming years following the legalization of adult-use cannabis. Investors have many different options for gaining exposure to the industry, but FinCanna Capital Corp. represents one of the most compelling opportunities given its diversification and scalability. Investors interested in learning more can sign-up to receive more information here.
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
CannabisFN.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. CannabisFN.com received fees for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.